Mirati Therapeutics Investor Relations Material
Latest events
Q2 2023
Mirati Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mirati Therapeutics Inc
Access all reports
Mirati Therapeutics Inc. is a clinical-stage biotechnology company focused on developing targeted cancer therapies. The company specializes in the research and development of treatments aimed at addressing genetic and epigenetic drivers of cancer. Mirati’s pipeline includes precision oncology candidates designed to inhibit specific molecular targets associated with tumor growth and progression. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
MRTX
Country
🇺🇸 United States